Performing Toxicology Screens with Automated Analysis

Drug abuse is an international health concern that incurs high costs, both to humans and the law.

In a number of countries, legal sentences and programs have been created to assist drug users in escaping their addiction and returning to society as a healthy and responsible person. Drug screening is a crucial element of these programs for tracking compliance.

Automatic testing is more efficient and decreases the inaccuracies that arise from human error. A fully automated drug testing procedure that follows from chain of custody to testing and simple reporting of results is the most effective evidence-based system provided for testing.

A key component of these programs is dynamic randomized testing with participant tracking and electronic reporting. The main aim is to make participants more successful when completing drug court programs.

A novel range of automated chemistry analyzers by AMS Alliance includes features and technologies that assist in these testing procedures. Randomized testing can be scheduled by laboratory software.

The attendance of participants over the complete course of their program can be traced through these software programs. Barcodes applied on specimen tubes assure chain of custody, which is checked by the barcode reader on the AMS analyzer.

AMS provides 19 unique urine DOA tests, which test for both street and prescription drugs. Specimen validity investigations can discover if participants have tampered with specimens through adulteration or dilution.

Daily and weekly checks are carried out utilizing controls and calibrators to ensure the accuracy of test results. This is critical because accredited system checks can be provided as evidence to support the routine validation of testing.  

It is sometimes argued by professionals that POC tests are the most inexpensive and simplest solution for drug testing requirements. In reality, these tests take too much time and the results can be unclear, leading to repeat testing and subjective analysis of results. The AMS SAT 450 Analyzer automatically performs the chosen tests on the sample and returns reliable, traceable results the first time.

For true unattended operation, up to 60 samples can be loaded up on board and each can have specific methods scheduled. The efficiency of the drug testing system reduces hands-on time and accelerates testing for accurate and quick results. The randomized access option of the SAT 450 enables participant samples to be added by the user during an active run.

The automation of drug testing increases the efficiency of in-house testing procedures. The solution enables reports to be kept in one database, with access to historical data for participants, and makes tracking and chain of custody reliable and simple.

DAU Assays, Controls, and Calibrators

  • Amphetamines
  • Buprenorphine
  • Barbiturates
  • Benzodiazepine
  • Cotinine
  • Cocaine
  • Ethyl Alcohol
  • Ethyl glucuronide (EtG)
  • Ecstasy
  • Heroin metabolite
  • Methadone metabolite (6-Acetylmorphine)
  • Methamphetamine
  • Methadone
  • Oxycodone
  • Opiate
  • Propoxyphene
  • Phencyclidine (PCP)
  • Synthetic cannabinoids
  • THC

AMS Alliance additionally creates the calibration standards and reagents, which makes this toxicology turn-key. Along with the SAT 450 analyzer, this provides cost-effective and dependable testing for high and medium-volume testing laboratories.

About AMS Alliance

AMS Alliance , A KPM Analytics brand, is a leading Group with headquarter in the Rome area (Italy) with subsidiaries in the USA, France, and China, and focuses on Medical Diagnostics, Molecular Biology/Microarrays, Food Diagnostics, Environment/Industry, Nuclear/Biology Isolation.

AMS Alliance has manufacturing facilities in Europe and the USA and markets its products via subsidiaries and a network of established distributors in 45 countries. 

KPM Analytics is a global leader in analytical instrumentation primarily focused on analyzing critical parameters within the food, agriculture, clinical and environmental sectors. provide a comprehensive range of products and services to solve our customers problems. Each of our brands has a long history of providing advanced and reliable analysis solutions to ensure product and process quality.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Aug 17, 2020 at 3:12 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AMS Alliance. (2020, August 17). Performing Toxicology Screens with Automated Analysis. News-Medical. Retrieved on September 28, 2020 from https://www.news-medical.net/whitepaper/20200817/Performing-Toxicology-Screens-with-Automated-Analysis.aspx.

  • MLA

    AMS Alliance. "Performing Toxicology Screens with Automated Analysis". News-Medical. 28 September 2020. <https://www.news-medical.net/whitepaper/20200817/Performing-Toxicology-Screens-with-Automated-Analysis.aspx>.

  • Chicago

    AMS Alliance. "Performing Toxicology Screens with Automated Analysis". News-Medical. https://www.news-medical.net/whitepaper/20200817/Performing-Toxicology-Screens-with-Automated-Analysis.aspx. (accessed September 28, 2020).

  • Harvard

    AMS Alliance. 2020. Performing Toxicology Screens with Automated Analysis. News-Medical, viewed 28 September 2020, https://www.news-medical.net/whitepaper/20200817/Performing-Toxicology-Screens-with-Automated-Analysis.aspx.